Tancredi, R., Negri, S., Cattrini, C., Ponchio, L., Frascaroli, M., Daprada, G., et al. (2013). SAFETY PROFILE AND TOLERABILITY OF 'TRABECTEDIN AND INDOLE-3-CARBINOL COMBINATION IN REFRACTORY ADVANCED BREAST CANCER. PRELIMINARY RESULTS OF PHASE 1 CLINICAL STUDY. In Advanced Breast Cancer Second International Consensus Conference (ABC2) 7-9 November 2013 • Lisbon, Portugal (pp.44-44). CHURCHILL LIVINGSTONE [10.1016/S0960-9776(13)70085-7].

SAFETY PROFILE AND TOLERABILITY OF 'TRABECTEDIN AND INDOLE-3-CARBINOL COMBINATION IN REFRACTORY ADVANCED BREAST CANCER. PRELIMINARY RESULTS OF PHASE 1 CLINICAL STUDY

Zambelli A
2013

abstract
Oncology; Obstetrics; Gynecology
English
Advanced Breast Cancer Second International Consensus Conference (ABC2) - 7-9 November 2013
2013
Advanced Breast Cancer Second International Consensus Conference (ABC2) 7-9 November 2013 • Lisbon, Portugal
2013
22
S3
44
44
none
Tancredi, R., Negri, S., Cattrini, C., Ponchio, L., Frascaroli, M., Daprada, G., et al. (2013). SAFETY PROFILE AND TOLERABILITY OF 'TRABECTEDIN AND INDOLE-3-CARBINOL COMBINATION IN REFRACTORY ADVANCED BREAST CANCER. PRELIMINARY RESULTS OF PHASE 1 CLINICAL STUDY. In Advanced Breast Cancer Second International Consensus Conference (ABC2) 7-9 November 2013 • Lisbon, Portugal (pp.44-44). CHURCHILL LIVINGSTONE [10.1016/S0960-9776(13)70085-7].
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/560704
Citazioni
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 0
Social impact